Zhirong Yang

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China

Penghui Shang, Yinyin Xia, Feiying Liu et al. · PLoS ONE · 2011 · 127 citations · Full text

Public Health, Infectious Diseases, Pharmacology +17

Adverse Reactions Due to Directly Observed Treatment Strategy Therapy in Chinese Tuberculosis Patients: A Prospective Study

Xiaozhen Lv, Shaowen Tang, Yinyin Xia et al. · PLoS ONE · 2013 · 105 citations · Full text

Public Health, Infectious Disease Control, Clinical Epidemiology +12

[Risk on bias assessment: (2) Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0)].

Zhirong Yang, Feng Sun, Siyan Zhan · PubMed · 2017 · 68 citations

Public Health, Biostatistics, Evidence-based Practice +15

<i>CYP2E1</i>,<i>GSTM1</i>and<i>GSTT1</i>genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study

Shaowen Tang, Xiaozhen Lv, Yuan Zhang et al. · Journal of Clinical Pharmacy and Therapeutics · 2012 · 56 citations

Medicine, Genetics, Pharmacology +15

Scoring systems to screen for diabetic peripheral neuropathy

Zhirong Yang, Ru Chen, Yuan Zhang et al. · Cochrane Database of Systematic Reviews · 2014 · 52 citations

Medicine, Internal Medicine, Neurology +12